Tugce Kahraman Demir
Overview
Explore the profile of Tugce Kahraman Demir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hajebrahimi F, Budak M, Saricaoglu M, Temel Z, Demir T, Hanoglu L, et al.
Brain Behav
. 2024 Feb;
14(1):e3395.
PMID: 38376051
Introduction: Cognitive impairment (CI) is a significant non-motor symptoms in Parkinson's disease (PD) that often precedes the emergence of motor symptoms by several years. Patients with PD hypothetically progress from...
2.
Arikan M, Demir T, Yildiz Z, Yilmaz N, Sen A, Hanoglu L, et al.
Mikrobiyol Bul
. 2024 Jan;
58(1):13-28.
PMID: 38263937
Although it is known that the relative abundance of Akkermansia, a bacterial genus commonly associated with health, increases in the gut microbiota of Parkinson's disease (PD) patients, the exact reason...
3.
Arikan M, Demir T, Yildiz Z, Nalbantoglu O, Korkmaz N, Yilmaz N, et al.
NPJ Biofilms Microbiomes
. 2023 Nov;
9(1):86.
PMID: 37980417
Cognitive impairment (CI) is very common in patients with Parkinson's Disease (PD) and progressively develops on a spectrum from mild cognitive impairment (PD-MCI) to full dementia (PDD). Identification of PD...
4.
Arikan M, Yildiz Z, Demir T, Yilmaz N, Sen A, Hanoglu L, et al.
Microbiol Spectr
. 2022 Feb;
10(1):e0235821.
PMID: 35138147
Cognitive impairment (CI) is among the most common non-motor symptoms of Parkinson's disease (PD), with a substantially negative impact on patient management and outcome. The development and progression of CI...